Quantum-Si incorporated (QSI)
NASDAQ: QSI · Real-Time Price · USD
1.520
-0.060 (-3.80%)
At close: Nov 12, 2025, 4:00 PM EST
1.500
-0.020 (-1.32%)
After-hours: Nov 12, 2025, 7:59 PM EST
Quantum-Si incorporated Revenue
Quantum-Si incorporated had revenue of $552.00K in the quarter ending September 30, 2025, a decrease of -29.86%. This brings the company's revenue in the last twelve months to $3.18M, up 40.20% year-over-year. In the year 2024, Quantum-Si incorporated had annual revenue of $3.06M with 182.62% growth.
Revenue (ttm)
$3.18M
Revenue Growth
+40.20%
P/S Ratio
86.35
Revenue / Employee
$21,322
Employees
149
Market Cap
327.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.06M | 1.98M | 182.62% |
| Dec 31, 2023 | 1.08M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
QSI News
- 7 days ago - Quantum-Si incorporated (QSI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Quantum-Si Reports Third Quarter 2025 Financial Results - Business Wire
- 23 days ago - Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Business Wire
- 4 weeks ago - Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025 - Business Wire
- 7 weeks ago - Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025 - Business Wire
- 2 months ago - Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing - Business Wire
- 3 months ago - Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire